Study of the Turkish General Sleep Disturbance Scale GSDS-T in Adults with Multiple Sclerosis

What this Trial Is About

Researchers are studying the Turkish version of the General Sleep Disturbance Scale GSDS-T to evaluate its validity and reliability in patients with multiple sclerosis MS. The GSDS-T assesses difficulties falling asleep, waking during sleep, overall sleep quality, and daytime alertness. Although the scale has been validated in Turkish stroke patients, this study aims to confirm its accuracy specifically for MS patients. This observational study involves 126 participants diagnosed with MS. The GSDS-T, consisting of 21 questions, will be administered along with the Pittsburgh Sleep Quality Index PSQI, a validated Turkish tool for assessing sleep quality. To measure test-retest reliability, these scales will be repeated after 15 days. Participants will complete the sleep disturbance and sleep quality assessments at baseline and again two weeks later. The study monitors and compares these results to evaluate the GSDS-Ts consistency and accuracy in this population. The total participation timeline includes the initial assessment and a follow-up after 15 days to review changes or stability in responses.

Reliability and Validity of the Turkish Version of General Sleep Disturbance Scale (GSDS-T) in Multiple Sclerosis